Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) is a Healthcare company (Biotechnology) with a market capitalization of $318M. The Maz Rating grades it against the other companies in its sector.
Atea Pharmaceuticals, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.96, Atea Pharmaceuticals, Inc. trades at 1.8x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -69.9%, return on invested capital of -93.8% and a free cash flow yield of -44.4%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 8.00. Over the past 52 weeks the share price ranged from $2.92 to $6.45, with a beta of 0.28.
Atea Pharmaceuticals, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 1 Buy, 2 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.